Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree

BACKGROUND: The results of two randomized phase 3 trials that investigated the use of laquinimod in patients with relapsing-remitting multiple sclerosis were analyzed using a propensity score model. METHODS: The propensity score in each study was defined as the probability of an individual patient b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutter, Gary R., Knappertz, Volker, Sasson, Nissim, Ladkani, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027083/
https://www.ncbi.nlm.nih.gov/pubmed/27639853
http://dx.doi.org/10.1186/s12883-016-0702-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027083/
https://www.ncbi.nlm.nih.gov/pubmed/27639853
http://dx.doi.org/10.1186/s12883-016-0702-4

Ejemplares similares